Personal tools

Difference between revisions of "FF:10008-101B6"

From FANTOM5_SSTAR

Jump to: navigation, search
Line 37: Line 37:
 
|id=FF:10008-101B6
 
|id=FF:10008-101B6
 
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343;;UBERON:0000479
 
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343;;UBERON:0000479
 +
|is_obsolete=
 
|name=Universal RNA - Mouse Normal Tissues Biochain, pool1
 
|name=Universal RNA - Mouse Normal Tissues Biochain, pool1
 
|namespace=FANTOM5
 
|namespace=FANTOM5
Line 69: Line 70:
 
|sample_ethnicity=
 
|sample_ethnicity=
 
|sample_experimental_condition=
 
|sample_experimental_condition=
 +
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;7.46992100277985e-285!GO:0005737;cytoplasm;5.37404497511534e-187!GO:0044444;cytoplasmic part;2.64666269684433e-146!GO:0043227;membrane-bound organelle;1.31156809254411e-98!GO:0043231;intracellular membrane-bound organelle;1.31156809254411e-98!GO:0043226;organelle;1.29614982989098e-91!GO:0043229;intracellular organelle;2.27751010529499e-91!GO:0044422;organelle part;1.29760063803816e-70!GO:0044446;intracellular organelle part;2.49304934452194e-69!GO:0005515;protein binding;1.48841268121233e-67!GO:0005739;mitochondrion;1.61870492256829e-61!GO:0044237;cellular metabolic process;1.54416981096145e-57!GO:0044238;primary metabolic process;1.32785055452382e-53!GO:0031090;organelle membrane;2.75531775683061e-51!GO:0009058;biosynthetic process;4.7654289601482e-41!GO:0032991;macromolecular complex;4.91917644459102e-41!GO:0044429;mitochondrial part;2.1858209826857e-40!GO:0043233;organelle lumen;1.90596077746375e-39!GO:0031974;membrane-enclosed lumen;1.90596077746375e-39!GO:0030529;ribonucleoprotein complex;3.27996269916542e-39!GO:0019538;protein metabolic process;2.80261730276012e-37!GO:0005783;endoplasmic reticulum;4.45558207630002e-37!GO:0044249;cellular biosynthetic process;6.73519884479733e-35!GO:0044260;cellular macromolecule metabolic process;5.31754051079132e-33!GO:0005829;cytosol;6.86565387295978e-33!GO:0044267;cellular protein metabolic process;1.5815024906932e-31!GO:0003723;RNA binding;2.11377012044245e-31!GO:0016491;oxidoreductase activity;5.43755490244726e-31!GO:0031967;organelle envelope;5.62444838032612e-31!GO:0031975;envelope;1.19279138017849e-30!GO:0033036;macromolecule localization;7.61975850211044e-30!GO:0015031;protein transport;5.63967850285998e-29!GO:0006412;translation;9.6414852114145e-29!GO:0045184;establishment of protein localization;2.91008503514012e-28!GO:0043170;macromolecule metabolic process;4.09261787581334e-28!GO:0008104;protein localization;8.13750377535582e-28!GO:0044432;endoplasmic reticulum part;1.48028054048631e-27!GO:0009059;macromolecule biosynthetic process;9.54635428459664e-27!GO:0016043;cellular component organization and biogenesis;1.83129047569803e-26!GO:0005840;ribosome;3.00714098142152e-26!GO:0005740;mitochondrial envelope;1.36194326309988e-25!GO:0006082;organic acid metabolic process;2.38399974341202e-25!GO:0031966;mitochondrial membrane;3.28072941965294e-25!GO:0019752;carboxylic acid metabolic process;1.41010901981064e-24!GO:0019866;organelle inner membrane;2.1321668266889e-24!GO:0044428;nuclear part;3.45007503855753e-24!GO:0012505;endomembrane system;5.64098291110158e-24!GO:0044248;cellular catabolic process;1.9485096711456e-23!GO:0005743;mitochondrial inner membrane;2.01518798762524e-23!GO:0003735;structural constituent of ribosome;1.29054890782908e-22!GO:0005789;endoplasmic reticulum membrane;1.89943127187344e-22!GO:0042175;nuclear envelope-endoplasmic reticulum network;2.46222832313423e-22!GO:0046907;intracellular transport;6.53395513875638e-22!GO:0006950;response to stress;1.74317694164866e-21!GO:0044255;cellular lipid metabolic process;2.32183482616166e-21!GO:0006629;lipid metabolic process;2.84333807503569e-21!GO:0031980;mitochondrial lumen;1.55905090693986e-20!GO:0005759;mitochondrial matrix;1.55905090693986e-20!GO:0006886;intracellular protein transport;2.09694423196982e-20!GO:0033279;ribosomal subunit;2.32388679562588e-20!GO:0043234;protein complex;4.80376235065462e-20!GO:0006091;generation of precursor metabolites and energy;2.36397257070569e-19!GO:0016071;mRNA metabolic process;3.46693233749501e-19!GO:0008380;RNA splicing;7.50579067432954e-19!GO:0009056;catabolic process;1.11835043794192e-17!GO:0009055;electron carrier activity;2.77520519507339e-17!GO:0006119;oxidative phosphorylation;5.13033547094936e-17!GO:0048770;pigment granule;6.79482633276789e-17!GO:0042470;melanosome;6.79482633276789e-17!GO:0065003;macromolecular complex assembly;6.93618789225658e-17!GO:0032787;monocarboxylic acid metabolic process;2.17248303014166e-16!GO:0006396;RNA processing;1.05022263688411e-15!GO:0006397;mRNA processing;1.13047231491538e-15!GO:0008134;transcription factor binding;1.74914037639139e-15!GO:0031981;nuclear lumen;2.92948788376724e-15!GO:0051186;cofactor metabolic process;3.49177961654939e-15!GO:0005830;cytosolic ribosome (sensu Eukaryota);4.98722815702508e-15!GO:0022607;cellular component assembly;5.5254915229708e-15!GO:0016192;vesicle-mediated transport;5.81621415631333e-14!GO:0006457;protein folding;5.89502627714754e-14!GO:0051641;cellular localization;1.2073586019411e-13!GO:0005681;spliceosome;1.75384980899282e-13!GO:0051649;establishment of cellular localization;2.07089084627797e-13!GO:0044445;cytosolic part;6.59624532181937e-13!GO:0008219;cell death;6.86382340729828e-13!GO:0016265;death;6.86382340729828e-13!GO:0044265;cellular macromolecule catabolic process;8.33256759579155e-13!GO:0006118;electron transport;1.66005336274316e-12!GO:0012501;programmed cell death;1.693117078191e-12!GO:0006915;apoptosis;1.78242247768353e-12!GO:0002526;acute inflammatory response;2.04056841220224e-12!GO:0005794;Golgi apparatus;2.60448764566308e-12!GO:0044455;mitochondrial membrane part;3.15222440758724e-12!GO:0048523;negative regulation of cellular process;3.53794943535562e-12!GO:0009611;response to wounding;4.37800539894511e-12!GO:0005746;mitochondrial respiratory chain;4.68373366115867e-12!GO:0015935;small ribosomal subunit;5.83424337719236e-12!GO:0048037;cofactor binding;6.41561232759232e-12!GO:0006732;coenzyme metabolic process;6.57383235470266e-12!GO:0005773;vacuole;8.24950419192052e-12!GO:0048519;negative regulation of biological process;1.0195956337534e-11!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;1.39015781766642e-11!GO:0016874;ligase activity;1.44131233607433e-11!GO:0051603;proteolysis involved in cellular protein catabolic process;2.92445462967981e-11!GO:0006605;protein targeting;3.71393952300719e-11!GO:0005792;microsome;4.18613214893171e-11!GO:0019941;modification-dependent protein catabolic process;5.82323323032291e-11!GO:0043632;modification-dependent macromolecule catabolic process;5.82323323032291e-11!GO:0050136;NADH dehydrogenase (quinone) activity;6.2758825945683e-11!GO:0003954;NADH dehydrogenase activity;6.2758825945683e-11!GO:0008137;NADH dehydrogenase (ubiquinone) activity;6.2758825945683e-11!GO:0006511;ubiquitin-dependent protein catabolic process;6.8560976156155e-11!GO:0042598;vesicular fraction;8.3153910789204e-11!GO:0006807;nitrogen compound metabolic process;8.32666557383416e-11!GO:0008202;steroid metabolic process;8.68387866563805e-11!GO:0044257;cellular protein catabolic process;9.11100810806044e-11!GO:0022618;protein-RNA complex assembly;1.09174421122576e-10!GO:0051082;unfolded protein binding;1.1094350333767e-10!GO:0005634;nucleus;1.41961960946433e-10!GO:0000323;lytic vacuole;1.52708387681832e-10!GO:0005764;lysosome;1.52708387681832e-10!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.55453777510341e-10!GO:0005654;nucleoplasm;1.86318466053837e-10!GO:0009057;macromolecule catabolic process;2.58745261482378e-10!GO:0005793;ER-Golgi intermediate compartment;4.45330995744439e-10!GO:0000502;proteasome complex (sensu Eukaryota);5.63968478322052e-10!GO:0002541;activation of plasma proteins during acute inflammatory response;7.16260987810462e-10!GO:0006956;complement activation;7.16260987810462e-10!GO:0051246;regulation of protein metabolic process;9.95193718127672e-10!GO:0008610;lipid biosynthetic process;1.11138917882184e-09!GO:0003712;transcription cofactor activity;1.4793139980921e-09!GO:0048193;Golgi vesicle transport;1.65545239629298e-09!GO:0006066;alcohol metabolic process;1.68069414544687e-09!GO:0043285;biopolymer catabolic process;1.86709989803612e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.95101183700175e-09!GO:0006958;complement activation, classical pathway;1.95601691148782e-09!GO:0015934;large ribosomal subunit;2.1078037168801e-09!GO:0006631;fatty acid metabolic process;2.4246721197389e-09!GO:0050662;coenzyme binding;3.32419296251639e-09!GO:0030964;NADH dehydrogenase complex (quinone);3.84120868979917e-09!GO:0045271;respiratory chain complex I;3.84120868979917e-09!GO:0005747;mitochondrial respiratory chain complex I;3.84120868979917e-09!GO:0006461;protein complex assembly;3.89387310942736e-09!GO:0005768;endosome;4.32949965928596e-09!GO:0042775;organelle ATP synthesis coupled electron transport;4.47258676534364e-09!GO:0042773;ATP synthesis coupled electron transport;4.47258676534364e-09!GO:0009308;amine metabolic process;5.40267991777989e-09!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);6.1729275135946e-09!GO:0008135;translation factor activity, nucleic acid binding;6.4448290258681e-09!GO:0002455;humoral immune response mediated by circulating immunoglobulin;6.56393537119665e-09!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;7.3949117951762e-09!GO:0030163;protein catabolic process;1.02759922130147e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.5827074803859e-08!GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;1.63500283427319e-08!GO:0043069;negative regulation of programmed cell death;1.63830711464678e-08!GO:0044451;nucleoplasm part;1.69190698806085e-08!GO:0006520;amino acid metabolic process;1.73734043536544e-08!GO:0043066;negative regulation of apoptosis;2.04991879606118e-08!GO:0016125;sterol metabolic process;2.56779025807645e-08!GO:0006446;regulation of translational initiation;2.9996927922789e-08!GO:0000166;nucleotide binding;3.26744907502041e-08!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;3.46559758286304e-08!GO:0006519;amino acid and derivative metabolic process;3.46559758286304e-08!GO:0016817;hydrolase activity, acting on acid anhydrides;3.6517930721803e-08!GO:0006913;nucleocytoplasmic transport;3.70472482279657e-08!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;4.24949764283093e-08!GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;4.4959739322032e-08!GO:0005761;mitochondrial ribosome;4.8070042376279e-08!GO:0000313;organellar ribosome;4.8070042376279e-08!GO:0016044;membrane organization and biogenesis;4.92165222585355e-08!GO:0016462;pyrophosphatase activity;5.15087551129054e-08!GO:0051169;nuclear transport;8.63165124155342e-08!GO:0042981;regulation of apoptosis;1.36010308097346e-07!GO:0031988;membrane-bound vesicle;1.49318443374209e-07!GO:0017111;nucleoside-triphosphatase activity;1.72571446179551e-07!GO:0031982;vesicle;1.77246613920812e-07!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.87666805441028e-07!GO:0006996;organelle organization and biogenesis;2.1656198059772e-07!GO:0008203;cholesterol metabolic process;2.31366398486456e-07!GO:0005777;peroxisome;2.53416358674136e-07!GO:0042579;microbody;2.53416358674136e-07!GO:0008565;protein transporter activity;2.55618539072591e-07!GO:0043067;regulation of programmed cell death;2.74916968905807e-07!GO:0016564;transcription repressor activity;2.7747442943394e-07!GO:0015986;ATP synthesis coupled proton transport;2.88602510669138e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;2.88602510669138e-07!GO:0016023;cytoplasmic membrane-bound vesicle;3.25096084659484e-07!GO:0051187;cofactor catabolic process;3.43259144779961e-07!GO:0006916;anti-apoptosis;3.50198890867682e-07!GO:0031410;cytoplasmic vesicle;4.05860576525131e-07!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);4.24168773754291e-07!GO:0006413;translational initiation;4.61741725281172e-07!GO:0003743;translation initiation factor activity;5.43063391303314e-07!GO:0051789;response to protein stimulus;5.74921514706258e-07!GO:0006986;response to unfolded protein;5.74921514706258e-07!GO:0045333;cellular respiration;6.3000323479833e-07!GO:0007599;hemostasis;6.69468441073526e-07!GO:0030036;actin cytoskeleton organization and biogenesis;7.63399742639967e-07!GO:0007596;blood coagulation;8.52952350388605e-07!GO:0017038;protein import;9.72787169862371e-07!GO:0044262;cellular carbohydrate metabolic process;9.90841264053286e-07!GO:0009060;aerobic respiration;1.01501659745538e-06!GO:0002253;activation of immune response;1.46523368056022e-06!GO:0015980;energy derivation by oxidation of organic compounds;1.48466345488798e-06!GO:0005635;nuclear envelope;1.57204090352961e-06!GO:0016604;nuclear body;1.65043115554965e-06!GO:0006954;inflammatory response;1.81886434004811e-06!GO:0000398;nuclear mRNA splicing, via spliceosome;1.82169088496342e-06!GO:0000375;RNA splicing, via transesterification reactions;1.82169088496342e-06!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.82169088496342e-06!GO:0009605;response to external stimulus;1.99172195865811e-06!GO:0019829;cation-transporting ATPase activity;1.99976466420245e-06!GO:0042060;wound healing;2.00064814647297e-06!GO:0006512;ubiquitin cycle;2.08606143265038e-06!GO:0050817;coagulation;2.14642918884886e-06!GO:0042221;response to chemical stimulus;2.23739271089871e-06!GO:0006752;group transfer coenzyme metabolic process;2.26113413492839e-06!GO:0019899;enzyme binding;2.26132314388655e-06!GO:0006869;lipid transport;2.28071909752287e-06!GO:0006366;transcription from RNA polymerase II promoter;2.35037821353538e-06!GO:0016607;nuclear speck;2.44098886078695e-06!GO:0010467;gene expression;2.61494800305896e-06!GO:0006099;tricarboxylic acid cycle;2.6184403093438e-06!GO:0046356;acetyl-CoA catabolic process;2.6184403093438e-06!GO:0048518;positive regulation of biological process;2.9354551516011e-06!GO:0030029;actin filament-based process;3.10825573319567e-06!GO:0003714;transcription corepressor activity;3.24804418498974e-06!GO:0008361;regulation of cell size;3.49767074970883e-06!GO:0031324;negative regulation of cellular metabolic process;3.59445882231222e-06!GO:0006694;steroid biosynthetic process;3.74646117021709e-06!GO:0016049;cell growth;3.93219328439155e-06!GO:0009109;coenzyme catabolic process;3.969581776797e-06!GO:0007243;protein kinase cascade;4.05186493677409e-06!GO:0016469;proton-transporting two-sector ATPase complex;4.35627659389633e-06!GO:0051188;cofactor biosynthetic process;5.04490504988176e-06!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;5.06485698435385e-06!GO:0008639;small protein conjugating enzyme activity;5.38921090892192e-06!GO:0005319;lipid transporter activity;5.68334622515196e-06!GO:0031252;leading edge;5.68334622515196e-06!GO:0008092;cytoskeletal protein binding;6.3899402960531e-06!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;6.47103405386978e-06!GO:0004842;ubiquitin-protein ligase activity;6.59855062130988e-06!GO:0042802;identical protein binding;8.46823591114979e-06!GO:0006957;complement activation, alternative pathway;8.63870435677151e-06!GO:0006084;acetyl-CoA metabolic process;8.82330221032035e-06!GO:0001558;regulation of cell growth;9.12691544877835e-06!GO:0005506;iron ion binding;9.4738510709457e-06!GO:0016064;immunoglobulin mediated immune response;9.51856825114649e-06!GO:0046034;ATP metabolic process;9.94913059699786e-06!GO:0006897;endocytosis;1.03427560172663e-05!GO:0010324;membrane invagination;1.03427560172663e-05!GO:0006754;ATP biosynthetic process;1.03531841154106e-05!GO:0006753;nucleoside phosphate metabolic process;1.03531841154106e-05!GO:0009892;negative regulation of metabolic process;1.10782045874513e-05!GO:0015078;hydrogen ion transmembrane transporter activity;1.19091073607643e-05!GO:0005788;endoplasmic reticulum lumen;1.19091073607643e-05!GO:0019439;aromatic compound catabolic process;1.19528317147964e-05!GO:0009199;ribonucleoside triphosphate metabolic process;1.20141731398556e-05!GO:0016879;ligase activity, forming carbon-nitrogen bonds;1.30346325492069e-05!GO:0044270;nitrogen compound catabolic process;1.33309184829196e-05!GO:0019787;small conjugating protein ligase activity;1.45968280462935e-05!GO:0009063;amino acid catabolic process;1.48833927803464e-05!GO:0006888;ER to Golgi vesicle-mediated transport;1.59193527538224e-05!GO:0051170;nuclear import;1.70106511125536e-05!GO:0005770;late endosome;1.70997121318485e-05!GO:0046483;heterocycle metabolic process;1.71216840650605e-05!GO:0009142;nucleoside triphosphate biosynthetic process;1.77622648481737e-05!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.77622648481737e-05!GO:0009205;purine ribonucleoside triphosphate metabolic process;1.88628486725409e-05!GO:0009144;purine nucleoside triphosphate metabolic process;1.88628486725409e-05!GO:0006606;protein import into nucleus;2.1205448925471e-05!GO:0019724;B cell mediated immunity;2.36769478489959e-05!GO:0005730;nucleolus;2.52173493284225e-05!GO:0009141;nucleoside triphosphate metabolic process;2.57408486842689e-05!GO:0017076;purine nucleotide binding;2.78281425312935e-05!GO:0000267;cell fraction;2.83556402347659e-05!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2.86564228948395e-05!GO:0009145;purine nucleoside triphosphate biosynthetic process;2.86564228948395e-05!GO:0030120;vesicle coat;3.04865188875708e-05!GO:0030662;coated vesicle membrane;3.04865188875708e-05!GO:0046930;pore complex;3.07633659840569e-05!GO:0046983;protein dimerization activity;3.60158100316705e-05!GO:0001666;response to hypoxia;3.8472406487848e-05!GO:0008286;insulin receptor signaling pathway;4.05344535054308e-05!GO:0048475;coated membrane;4.19813937405124e-05!GO:0030117;membrane coat;4.19813937405124e-05!GO:0009259;ribonucleotide metabolic process;4.28122285143847e-05!GO:0009310;amine catabolic process;4.56527492559309e-05!GO:0006613;cotranslational protein targeting to membrane;5.01031235635329e-05!GO:0016126;sterol biosynthetic process;5.01031235635329e-05!GO:0003713;transcription coactivator activity;5.10830456528936e-05!GO:0007249;I-kappaB kinase/NF-kappaB cascade;5.24522540117159e-05!GO:0006163;purine nucleotide metabolic process;5.60064903738726e-05!GO:0016787;hydrolase activity;6.32170363336321e-05!GO:0016853;isomerase activity;6.41974556215098e-05!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;6.89039958018706e-05!GO:0048522;positive regulation of cellular process;7.53287782542122e-05!GO:0005839;proteasome core complex (sensu Eukaryota);7.87718001067949e-05!GO:0009108;coenzyme biosynthetic process;8.15599180810287e-05!GO:0009150;purine ribonucleotide metabolic process;8.58310271173263e-05!GO:0001944;vasculature development;8.58330788924926e-05!GO:0000096;sulfur amino acid metabolic process;9.31894354041326e-05!GO:0005624;membrane fraction;9.77201157717337e-05!GO:0065008;regulation of biological quality;0.000108831300527001!GO:0019842;vitamin binding;0.000113539599921309!GO:0006695;cholesterol biosynthetic process;0.000113646955567775!GO:0031965;nuclear membrane;0.00011424838527691!GO:0006006;glucose metabolic process;0.000127435016055874!GO:0043412;biopolymer modification;0.000133753370591305!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.000137400385863102!GO:0044440;endosomal part;0.000141221534792921!GO:0010008;endosome membrane;0.000141221534792921!GO:0051287;NAD binding;0.00014172508823645!GO:0005791;rough endoplasmic reticulum;0.000154645195342951!GO:0045259;proton-transporting ATP synthase complex;0.000158888601827162!GO:0001568;blood vessel development;0.000159653464144324!GO:0015918;sterol transport;0.000203797688122094!GO:0030301;cholesterol transport;0.000203797688122094!GO:0030867;rough endoplasmic reticulum membrane;0.000205167716893961!GO:0043228;non-membrane-bound organelle;0.000206399662148445!GO:0043232;intracellular non-membrane-bound organelle;0.000206399662148445!GO:0006793;phosphorus metabolic process;0.000209406992625771!GO:0006796;phosphate metabolic process;0.000209406992625771!GO:0003779;actin binding;0.000223612005500097!GO:0006164;purine nucleotide biosynthetic process;0.000228399347485892!GO:0006417;regulation of translation;0.000239024761923427!GO:0006464;protein modification process;0.000241371810602318!GO:0010035;response to inorganic substance;0.000249832576069606!GO:0016881;acid-amino acid ligase activity;0.00025603380980102!GO:0044431;Golgi apparatus part;0.000276169932775192!GO:0016769;transferase activity, transferring nitrogenous groups;0.000306816203552612!GO:0003924;GTPase activity;0.000307768953395508!GO:0008652;amino acid biosynthetic process;0.000328003481806243!GO:0009260;ribonucleotide biosynthetic process;0.000328003481806243!GO:0016887;ATPase activity;0.000328003481806243!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000331908670598979!GO:0005579;membrane attack complex;0.000344782345985111!GO:0009152;purine ribonucleotide biosynthetic process;0.000351373789112438!GO:0016563;transcription activator activity;0.000363729693198674!GO:0019318;hexose metabolic process;0.000364183946069064!GO:0005996;monosaccharide metabolic process;0.000364183946069064!GO:0043283;biopolymer metabolic process;0.000373698649135722!GO:0031326;regulation of cellular biosynthetic process;0.00038250644427218!GO:0032553;ribonucleotide binding;0.000383291384269286!GO:0032555;purine ribonucleotide binding;0.000383291384269286!GO:0050878;regulation of body fluid levels;0.000422754251683979!GO:0040008;regulation of growth;0.000437278567889529!GO:0006612;protein targeting to membrane;0.000454442483616191!GO:0007264;small GTPase mediated signal transduction;0.000454922041840049!GO:0004298;threonine endopeptidase activity;0.000454922041840049!GO:0016481;negative regulation of transcription;0.000469290413269418!GO:0009889;regulation of biosynthetic process;0.00050122274458286!GO:0006979;response to oxidative stress;0.000503384311689939!GO:0005525;GTP binding;0.000545013873414184!GO:0006508;proteolysis;0.000559973181002392!GO:0045786;negative regulation of progression through cell cycle;0.000582751331794523!GO:0006959;humoral immune response;0.000596202525294406!GO:0008654;phospholipid biosynthetic process;0.000598843329746399!GO:0050789;regulation of biological process;0.000664002317355859!GO:0005741;mitochondrial outer membrane;0.000725288019606605!GO:0005798;Golgi-associated vesicle;0.000758767607989268!GO:0005975;carbohydrate metabolic process;0.000768382880317884!GO:0031968;organelle outer membrane;0.000768382880317884!GO:0009074;aromatic amino acid family catabolic process;0.000780528304980648!GO:0043687;post-translational protein modification;0.000789515870158419!GO:0022890;inorganic cation transmembrane transporter activity;0.000804451242331896!GO:0010033;response to organic substance;0.000812639048054162!GO:0030139;endocytic vesicle;0.000814219467293434!GO:0000097;sulfur amino acid biosynthetic process;0.000842242897068842!GO:0043566;structure-specific DNA binding;0.000842537172872842!GO:0008250;oligosaccharyl transferase complex;0.000845422081085237!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000896314684060409!GO:0019867;outer membrane;0.000918865343352593!GO:0032446;protein modification by small protein conjugation;0.000918865343352593!GO:0046394;carboxylic acid biosynthetic process;0.000939283637917777!GO:0016053;organic acid biosynthetic process;0.000939283637917777!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.000963352503894115!GO:0044453;nuclear membrane part;0.000978196574755252!GO:0048471;perinuclear region of cytoplasm;0.000983650424057455!GO:0000245;spliceosome assembly;0.00104123309352825!GO:0004857;enzyme inhibitor activity;0.0011554270676991!GO:0030100;regulation of endocytosis;0.00117524860994833!GO:0016567;protein ubiquitination;0.00120592321555331!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00122540581007341!GO:0030133;transport vesicle;0.00124128368499514!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00130646249393227!GO:0004576;oligosaccharyl transferase activity;0.00133103474224431!GO:0030554;adenyl nucleotide binding;0.00140569970187609!GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;0.00143170001911801!GO:0042623;ATPase activity, coupled;0.0015048354573877!GO:0030212;hyaluronan metabolic process;0.00150966812358401!GO:0065007;biological regulation;0.00154041596173322!GO:0008206;bile acid metabolic process;0.00174480692392526!GO:0006518;peptide metabolic process;0.00175477213851732!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00177038013734334!GO:0016310;phosphorylation;0.00177481397811038!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.00189939639765178!GO:0051920;peroxiredoxin activity;0.00196688768212989!GO:0006487;protein amino acid N-linked glycosylation;0.00206729084261403!GO:0009719;response to endogenous stimulus;0.00214279954321622!GO:0051659;maintenance of mitochondrion localization;0.00215276218743443!GO:0051657;maintenance of organelle localization;0.00215276218743443!GO:0019395;fatty acid oxidation;0.00218415546050022!GO:0001726;ruffle;0.0021913437158706!GO:0006953;acute-phase response;0.00219610431982556!GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors;0.0022265636074606!GO:0006643;membrane lipid metabolic process;0.00227994172076278!GO:0045792;negative regulation of cell size;0.00234489080582131!GO:0033116;ER-Golgi intermediate compartment membrane;0.00243747056240184!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00252820302824898!GO:0016408;C-acyltransferase activity;0.002581661097979!GO:0030308;negative regulation of cell growth;0.00260688268220971!GO:0006725;aromatic compound metabolic process;0.00261704142527626!GO:0043021;ribonucleoprotein binding;0.00265484556738843!GO:0032561;guanyl ribonucleotide binding;0.00266590380073093!GO:0019001;guanyl nucleotide binding;0.00266590380073093!GO:0009069;serine family amino acid metabolic process;0.00266895736826269!GO:0033673;negative regulation of kinase activity;0.0027687057288564!GO:0006469;negative regulation of protein kinase activity;0.0027687057288564!GO:0048514;blood vessel morphogenesis;0.0027687057288564!GO:0051427;hormone receptor binding;0.0027687057288564!GO:0006558;L-phenylalanine metabolic process;0.00279243711354965!GO:0006559;L-phenylalanine catabolic process;0.00279243711354965!GO:0001525;angiogenesis;0.00281400108138202!GO:0030532;small nuclear ribonucleoprotein complex;0.00283387963705415!GO:0051270;regulation of cell motility;0.00283772436976524!GO:0003690;double-stranded DNA binding;0.00295012255708776!GO:0019843;rRNA binding;0.00296541248598091!GO:0050794;regulation of cellular process;0.00299675121747661!GO:0019838;growth factor binding;0.00310156986282477!GO:0004364;glutathione transferase activity;0.00310156986282477!GO:0005885;Arp2/3 protein complex;0.00315105912672191!GO:0005159;insulin-like growth factor receptor binding;0.00338870874577792!GO:0048468;cell development;0.00343774297556774!GO:0016197;endosome transport;0.00345972637746815!GO:0010038;response to metal ion;0.00353814397618851!GO:0008483;transaminase activity;0.00357059368514274!GO:0000139;Golgi membrane;0.00362320945992671!GO:0050657;nucleic acid transport;0.00362320945992671!GO:0051236;establishment of RNA localization;0.00362320945992671!GO:0050658;RNA transport;0.00362320945992671!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00362320945992671!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00362320945992671!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00362320945992671!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00362320945992671!GO:0030027;lamellipodium;0.00362320945992671!GO:0006635;fatty acid beta-oxidation;0.00366308295967802!GO:0055088;lipid homeostasis;0.0037178454346301!GO:0016859;cis-trans isomerase activity;0.00401226507895802!GO:0016860;intramolecular oxidoreductase activity;0.00409208278112317!GO:0005762;mitochondrial large ribosomal subunit;0.00409208278112317!GO:0000315;organellar large ribosomal subunit;0.00409208278112317!GO:0002449;lymphocyte mediated immunity;0.00429175682878343!GO:0031960;response to corticosteroid stimulus;0.00438722176840639!GO:0002684;positive regulation of immune system process;0.00440011774172165!GO:0005774;vacuolar membrane;0.00442958080849571!GO:0006403;RNA localization;0.00446958150621143!GO:0018196;peptidyl-asparagine modification;0.00451879033016531!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00451879033016531!GO:0035257;nuclear hormone receptor binding;0.00453850080482515!GO:0005643;nuclear pore;0.0046971778861068!GO:0044242;cellular lipid catabolic process;0.00471605702424134!GO:0016829;lyase activity;0.00474631006428962!GO:0045454;cell redox homeostasis;0.00477797341923301!GO:0045892;negative regulation of transcription, DNA-dependent;0.00483724747345329!GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;0.00485501535579704!GO:0002250;adaptive immune response;0.00485501535579704!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.00485501535579704!GO:0004300;enoyl-CoA hydratase activity;0.00489955623137682!GO:0000151;ubiquitin ligase complex;0.00502673899044077!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.00512586754056337!GO:0006693;prostaglandin metabolic process;0.00512586754056337!GO:0006692;prostanoid metabolic process;0.00512586754056337!GO:0007005;mitochondrion organization and biogenesis;0.00512586754056337!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.00512902056158762!GO:0016740;transferase activity;0.00513319685951381!GO:0009966;regulation of signal transduction;0.00514851690108434!GO:0003724;RNA helicase activity;0.00573159251218889!GO:0051540;metal cluster binding;0.00611964800624101!GO:0051536;iron-sulfur cluster binding;0.00611964800624101!GO:0005577;fibrinogen complex;0.00633917615219964!GO:0005769;early endosome;0.00645954635146555!GO:0051348;negative regulation of transferase activity;0.0065228947425094!GO:0050778;positive regulation of immune response;0.00713544713341641!GO:0009725;response to hormone stimulus;0.00751375958266763!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.007600426536732!GO:0048500;signal recognition particle;0.00790693861801071!GO:0006879;cellular iron ion homeostasis;0.00791112056512409!GO:0055072;iron ion homeostasis;0.00791112056512409!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00793886612758112!GO:0050660;FAD binding;0.00801459766982757!GO:0005905;coated pit;0.00833008787661899!GO:0042157;lipoprotein metabolic process;0.00834352999637022!GO:0051235;maintenance of localization;0.00848007280672402!GO:0000314;organellar small ribosomal subunit;0.00866791581360874!GO:0005763;mitochondrial small ribosomal subunit;0.00866791581360874!GO:0065002;intracellular protein transport across a membrane;0.00866791581360874!GO:0051087;chaperone binding;0.00892231492399916!GO:0030118;clathrin coat;0.00895888084483957!GO:0065009;regulation of a molecular function;0.00917490168953935!GO:0006644;phospholipid metabolic process;0.00925436534167986!GO:0030218;erythrocyte differentiation;0.00944884434965813!GO:0003697;single-stranded DNA binding;0.00954255507904283!GO:0045926;negative regulation of growth;0.00967312678837748!GO:0002682;regulation of immune system process;0.00974126044857536!GO:0008209;androgen metabolic process;0.00974887152387806!GO:0051128;regulation of cellular component organization and biogenesis;0.00985815701974564!GO:0009967;positive regulation of signal transduction;0.00985815701974564!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.00992584881110343!GO:0015399;primary active transmembrane transporter activity;0.00992584881110343!GO:0005524;ATP binding;0.0100475717839097!GO:0008047;enzyme activator activity;0.0100475717839097!GO:0006790;sulfur metabolic process;0.0101522889160909!GO:0030132;clathrin coat of coated pit;0.0106310564450974!GO:0002443;leukocyte mediated immunity;0.0111125850386839!GO:0040011;locomotion;0.0111682988138782!GO:0051252;regulation of RNA metabolic process;0.011222242306783!GO:0019210;kinase inhibitor activity;0.0113329601675268!GO:0040012;regulation of locomotion;0.0113329601675268!GO:0032559;adenyl ribonucleotide binding;0.0115233796856964!GO:0006767;water-soluble vitamin metabolic process;0.0116259725460833!GO:0005083;small GTPase regulator activity;0.0116504815018137!GO:0051384;response to glucocorticoid stimulus;0.0116608803856083!GO:0006650;glycerophospholipid metabolic process;0.0116625263780105!GO:0009081;branched chain family amino acid metabolic process;0.0117689700540174!GO:0008154;actin polymerization and/or depolymerization;0.0118209766022753!GO:0051101;regulation of DNA binding;0.0122954604352418!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.0126076737411523!GO:0004812;aminoacyl-tRNA ligase activity;0.0126076737411523!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.0126076737411523!GO:0030134;ER to Golgi transport vesicle;0.0126759584244512!GO:0002252;immune effector process;0.0127652578814941!GO:0030041;actin filament polymerization;0.0132374423105222!GO:0051179;localization;0.0132524350280178!GO:0009991;response to extracellular stimulus;0.0133423351989604!GO:0051248;negative regulation of protein metabolic process;0.0135680865816524!GO:0005667;transcription factor complex;0.0138767341786182!GO:0031589;cell-substrate adhesion;0.0144963397007763!GO:0004177;aminopeptidase activity;0.0144963397007763!GO:0006525;arginine metabolic process;0.0146532312192074!GO:0030127;COPII vesicle coat;0.0154061873633785!GO:0012507;ER to Golgi transport vesicle membrane;0.0154061873633785!GO:0043623;cellular protein complex assembly;0.0154182545074568!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0155512487431221!GO:0045047;protein targeting to ER;0.0155512487431221!GO:0004860;protein kinase inhibitor activity;0.0155849771110983!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.0155899285818057!GO:0007040;lysosome organization and biogenesis;0.0156329845076932!GO:0009117;nucleotide metabolic process;0.0157316706896731!GO:0035258;steroid hormone receptor binding;0.0158528571867976!GO:0044437;vacuolar part;0.016130673408342!GO:0015036;disulfide oxidoreductase activity;0.0162868228121075!GO:0008201;heparin binding;0.0166290505360489!GO:0006706;steroid catabolic process;0.0168495901367284!GO:0007050;cell cycle arrest;0.0169026658208344!GO:0043038;amino acid activation;0.0169026658208344!GO:0006418;tRNA aminoacylation for protein translation;0.0169026658208344!GO:0043039;tRNA aminoacylation;0.0169026658208344!GO:0007265;Ras protein signal transduction;0.0170986734110162!GO:0043492;ATPase activity, coupled to movement of substances;0.0171537143311421!GO:0006778;porphyrin metabolic process;0.0171537143311421!GO:0033013;tetrapyrrole metabolic process;0.0171537143311421!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0171537143311421!GO:0015002;heme-copper terminal oxidase activity;0.0171537143311421!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0171537143311421!GO:0004129;cytochrome-c oxidase activity;0.0171537143311421!GO:0043488;regulation of mRNA stability;0.0172041211592454!GO:0043487;regulation of RNA stability;0.0172041211592454!GO:0016709;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;0.0173894463146422!GO:0006572;tyrosine catabolic process;0.0174240790273508!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0175084235940649!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0176475972542998!GO:0006402;mRNA catabolic process;0.0179728005740223!GO:0031667;response to nutrient levels;0.0182930954154893!GO:0031072;heat shock protein binding;0.0182994123409098!GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;0.0182994123409098!GO:0055092;sterol homeostasis;0.0185149393151752!GO:0042632;cholesterol homeostasis;0.0185149393151752!GO:0004029;aldehyde dehydrogenase (NAD) activity;0.0185329334962003!GO:0030170;pyridoxal phosphate binding;0.0186472178280376!GO:0005852;eukaryotic translation initiation factor 3 complex;0.0189702118612644!GO:0006633;fatty acid biosynthetic process;0.0191858464455598!GO:0051591;response to cAMP;0.0193420141520093!GO:0046364;monosaccharide biosynthetic process;0.0194012798962036!GO:0046165;alcohol biosynthetic process;0.0194012798962036!GO:0017166;vinculin binding;0.0198857867253276!GO:0051028;mRNA transport;0.0199032840005828!GO:0043284;biopolymer biosynthetic process;0.0201566758748502!GO:0008186;RNA-dependent ATPase activity;0.0201784150188178!GO:0006702;androgen biosynthetic process;0.0201968520242056!GO:0051168;nuclear export;0.0202838914731814!GO:0048659;smooth muscle cell proliferation;0.0202838914731814!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.0202838914731814!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0206181748184286!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.020651906578437!GO:0051674;localization of cell;0.0207528608789785!GO:0006928;cell motility;0.0207528608789785!GO:0005520;insulin-like growth factor binding;0.0211466027709537!GO:0001887;selenium metabolic process;0.0216928279453989!GO:0042627;chylomicron;0.0218742075247714!GO:0016877;ligase activity, forming carbon-sulfur bonds;0.0221351274010242!GO:0008026;ATP-dependent helicase activity;0.0222210577092456!GO:0019904;protein domain specific binding;0.0222704304980348!GO:0007162;negative regulation of cell adhesion;0.0223974738222647!GO:0050811;GABA receptor binding;0.0223974738222647!GO:0003988;acetyl-CoA C-acyltransferase activity;0.0223974738222647!GO:0003729;mRNA binding;0.0226178739494533!GO:0006259;DNA metabolic process;0.0226178739494533!GO:0050776;regulation of immune response;0.0228425658582559!GO:0043681;protein import into mitochondrion;0.0228433846905189!GO:0005765;lysosomal membrane;0.023116653837023!GO:0016791;phosphoric monoester hydrolase activity;0.0232840966973261!GO:0005048;signal sequence binding;0.0235256262007471!GO:0045893;positive regulation of transcription, DNA-dependent;0.0239352490945377!GO:0042026;protein refolding;0.0240458067425557!GO:0007160;cell-matrix adhesion;0.0243873310272382!GO:0030658;transport vesicle membrane;0.0246603846504434!GO:0051726;regulation of cell cycle;0.0247546459166863!GO:0009066;aspartate family amino acid metabolic process;0.0252153124636969!GO:0050748;negative regulation of lipoprotein metabolic process;0.0252272200500039!GO:0000074;regulation of progression through cell cycle;0.0254456956749442!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0255517345401183!GO:0031327;negative regulation of cellular biosynthetic process;0.0260114352797901!GO:0045637;regulation of myeloid cell differentiation;0.0262079988566736!GO:0048487;beta-tubulin binding;0.0262646855822661!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0270326177574274!GO:0042168;heme metabolic process;0.0272035035515608!GO:0033344;cholesterol efflux;0.0272855381600819!GO:0006607;NLS-bearing substrate import into nucleus;0.0272855381600819!GO:0031902;late endosome membrane;0.0273088336541781!GO:0050749;apolipoprotein E receptor binding;0.0276194291916616!GO:0030518;steroid hormone receptor signaling pathway;0.0276340566426266!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0278127401654411!GO:0003746;translation elongation factor activity;0.0278480382606596!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0284559339335695!GO:0030176;integral to endoplasmic reticulum membrane;0.0285409959501704!GO:0046904;calcium oxalate binding;0.0286451618904833!GO:0030568;plasmin inhibitor activity;0.0286451618904833!GO:0015923;mannosidase activity;0.0288518031955188!GO:0030193;regulation of blood coagulation;0.0294197473962222!GO:0016836;hydro-lyase activity;0.0299701389628505!GO:0000041;transition metal ion transport;0.0300490409393548!GO:0003995;acyl-CoA dehydrogenase activity;0.0300908377528223!GO:0008312;7S RNA binding;0.0303290759007259!GO:0046467;membrane lipid biosynthetic process;0.0305193897672042!GO:0007010;cytoskeleton organization and biogenesis;0.0305333506423629!GO:0051537;2 iron, 2 sulfur cluster binding;0.0305967812050454!GO:0015682;ferric iron transport;0.0307567671909983!GO:0015091;ferric iron transmembrane transporter activity;0.0307567671909983!GO:0031643;positive regulation of myelination;0.0307567671909983!GO:0030119;AP-type membrane coat adaptor complex;0.0309375107980815!GO:0042803;protein homodimerization activity;0.0312678509063781!GO:0005938;cell cortex;0.0317588020576052!GO:0007033;vacuole organization and biogenesis;0.0317588020576052!GO:0019319;hexose biosynthetic process;0.0319363899915171!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0319831245456694!GO:0016229;steroid dehydrogenase activity;0.0324428725393658!GO:0042254;ribosome biogenesis and assembly;0.0327193632409581!GO:0030663;COPI coated vesicle membrane;0.0337412281291194!GO:0030126;COPI vesicle coat;0.0337412281291194!GO:0030155;regulation of cell adhesion;0.0337893281588789!GO:0051346;negative regulation of hydrolase activity;0.0339646817867721!GO:0042558;pteridine and derivative metabolic process;0.0340014670692938!GO:0004197;cysteine-type endopeptidase activity;0.0343201289795925!GO:0007242;intracellular signaling cascade;0.0346716791454078!GO:0006749;glutathione metabolic process;0.0353525462873986!GO:0051539;4 iron, 4 sulfur cluster binding;0.0353525462873986!GO:0051098;regulation of binding;0.0355474479491895!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.0358685778543418!GO:0006892;post-Golgi vesicle-mediated transport;0.0361995400095021!GO:0006509;membrane protein ectodomain proteolysis;0.0362554169341896!GO:0033619;membrane protein proteolysis;0.0362554169341896!GO:0030131;clathrin adaptor complex;0.0362554169341896!GO:0046686;response to cadmium ion;0.0363433373397523!GO:0000060;protein import into nucleus, translocation;0.0374021813556913!GO:0008430;selenium binding;0.0374840109907818!GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;0.0376466693352839!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.0377103750523752!GO:0006414;translational elongation;0.037813632120388!GO:0030569;chymotrypsin inhibitor activity;0.0379624489044481!GO:0006090;pyruvate metabolic process;0.0379981082380219!GO:0051271;negative regulation of cell motility;0.03802565828534!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0381197921549064!GO:0030695;GTPase regulator activity;0.0389511703669631!GO:0008139;nuclear localization sequence binding;0.0393116215161935!GO:0006081;aldehyde metabolic process;0.0401181582172746!GO:0030334;regulation of cell migration;0.0401181582172746!GO:0005099;Ras GTPase activator activity;0.0408486301688178!GO:0016746;transferase activity, transferring acyl groups;0.0408486301688178!GO:0050818;regulation of coagulation;0.0410015561250108!GO:0000050;urea cycle;0.0413169738015183!GO:0043603;amide metabolic process;0.0413169738015183!GO:0019627;urea metabolic process;0.0413169738015183!GO:0006818;hydrogen transport;0.0416106514715459!GO:0004386;helicase activity;0.0417534231960878!GO:0003702;RNA polymerase II transcription factor activity;0.0417538432728872!GO:0046395;carboxylic acid catabolic process;0.0424770059291789!GO:0016054;organic acid catabolic process;0.0424770059291789!GO:0051049;regulation of transport;0.0429216110126334!GO:0035035;histone acetyltransferase binding;0.0430471490337341!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0432678401649222!GO:0016747;transferase activity, transferring groups other than amino-acyl groups;0.0433619859516864!GO:0001889;liver development;0.0434115600955046!GO:0004004;ATP-dependent RNA helicase activity;0.0434115600955046!GO:0004563;beta-N-acetylhexosaminidase activity;0.043416816093658!GO:0006007;glucose catabolic process;0.0434277303530248!GO:0006595;polyamine metabolic process;0.0436180784716014!GO:0008283;cell proliferation;0.0443888122034401!GO:0004185;serine carboxypeptidase activity;0.0450391060778025!GO:0043065;positive regulation of apoptosis;0.0453068656943353!GO:0007049;cell cycle;0.0456874218986543!GO:0006534;cysteine metabolic process;0.0458450136476353!GO:0005539;glycosaminoglycan binding;0.0459139881472534!GO:0008147;structural constituent of bone;0.0465497325743208!GO:0005096;GTPase activator activity;0.0465497325743208!GO:0009890;negative regulation of biosynthetic process;0.0469443584041292!GO:0001725;stress fiber;0.0471657367949809!GO:0032432;actin filament bundle;0.0471657367949809!GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;0.0473162737059521!GO:0004784;superoxide dismutase activity;0.0473162737059521!GO:0005100;Rho GTPase activator activity;0.0479051640651027!GO:0006642;triacylglycerol mobilization;0.0487590185152018!GO:0009607;response to biotic stimulus;0.0488387134799287!GO:0005832;chaperonin-containing T-complex;0.0488647963606586!GO:0005542;folic acid binding;0.0488647963606586!GO:0048646;anatomical structure formation;0.0491824766366303
 
|sample_id=10008
 
|sample_id=10008
 
|sample_note=
 
|sample_note=
Line 76: Line 78:
 
|sample_tissue=whole body
 
|sample_tissue=whole body
 
|top_motifs=NR1H4:4.33669576105;HLF:4.25349855833;AR:3.55803759212;HNF1A:3.07291260649;NFIL3:2.85179065936;FOXA2:2.79295555977;HNF4A_NR2F1,2:2.5897924603;FOX{F1,F2,J1}:2.46730009914;NFIX:2.34813125642;ESRRA:2.24904849638;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.99247378841;TBP:1.89586746526;FOX{D1,D2}:1.79279189028;PAX1,9:1.78413894012;IRF7:1.69728095698;STAT2,4,6:1.55317055459;NR3C1:1.47320804567;JUN:1.46096487756;bHLH_family:1.43062490842;ESR1:1.36419431699;NR5A1,2:1.36088443716;NKX3-2:1.35138098019;TBX4,5:1.30777138852;MYB:1.24394962771;SNAI1..3:1.18919076864;T:1.09120619869;NR6A1:1.07178004575;CEBPA,B_DDIT3:1.05101438243;PPARG:1.04861708139;NFE2L1:1.0080353541;ZEB1:1.00445087371;ONECUT1,2:0.890146825116;SOX17:0.882358602252;MYOD1:0.839293668886;HAND1,2:0.794489525797;RFX1:0.790620460053;FOXM1:0.711017747061;FOXO1,3,4:0.66449693304;DMAP1_NCOR{1,2}_SMARC:0.618011784381;ATF6:0.561571608976;FOXN1:0.456465258133;TFCP2:0.376434025573;ZBTB6:0.373479008906;PDX1:0.372884397085;TLX1..3_NFIC{dimer}:0.35508229065;RFX2..5_RFXANK_RFXAP:0.337004398854;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.336343583965;PAX6:0.30139817992;PBX1:0.246262444348;FOSL2:0.21371876839;GATA6:0.21119316386;CUX2:0.198509001121;PAX5:0.12077581422;TP53:0.11712987743;ADNP_IRX_SIX_ZHX:0.111844497456;RXRA_VDR{dimer}:0.0969844177456;IRF1,2:0.086123589089;LMO2:0.0841818488891;GZF1:0.066582722117;TLX2:0.0654242590937;GCM1,2:0.014123252449;RBPJ:-0.0178011507238;MYBL2:-0.026462208928;HSF1,2:-0.0348520219673;MAFB:-0.042848048999;REST:-0.0568636076502;ATF5_CREB3:-0.101480400792;SRF:-0.130370723471;NFY{A,B,C}:-0.16718141828;ZNF148:-0.186796491513;LEF1_TCF7_TCF7L1,2:-0.19074552671;TFAP4:-0.197889059456;HOX{A5,B5}:-0.232269196609;STAT1,3:-0.24527216939;MEF2{A,B,C,D}:-0.249491335677;FOS_FOS{B,L1}_JUN{B,D}:-0.266039995085;HOXA9_MEIS1:-0.278472462782;OCT4_SOX2{dimer}:-0.308349911422;GTF2A1,2:-0.313896086094;HMGA1,2:-0.32049719811;RXR{A,B,G}:-0.332669194721;XCPE1{core}:-0.351560045467;NKX2-2,8:-0.364264931338;MYFfamily:-0.367932024705;POU6F1:-0.375761789312;ATF4:-0.379410789966;POU2F1..3:-0.384610499622;ETS1,2:-0.388736769453;SOX5:-0.3904423467;HIC1:-0.393678246847;ATF2:-0.394759549377;TEAD1:-0.420157086187;RUNX1..3:-0.443259282351;TGIF1:-0.480723023818;MTF1:-0.491150002144;GFI1:-0.494573945538;GFI1B:-0.506520278378;ALX1:-0.511993609052;NHLH1,2:-0.532181437146;PATZ1:-0.536308538171;TFAP2{A,C}:-0.540003977572;SREBF1,2:-0.566521214282;FOXL1:-0.569271896245;NFKB1_REL_RELA:-0.571932657702;SP1:-0.597988583849;SPI1:-0.654746679318;HMX1:-0.676229869058;MED-1{core}:-0.676370379993;PAX8:-0.725167035386;NFE2:-0.735415851694;TFAP2B:-0.738796401661;NKX2-3_NKX2-5:-0.748968263641;EBF1:-0.764639918753;HOX{A4,D4}:-0.770620269692;HIF1A:-0.790849855458;ALX4:-0.79118371793;GTF2I:-0.79330664257;POU1F1:-0.805177127056;NKX6-1,2:-0.82336810693;CREB1:-0.834009175763;MAZ:-0.834651704924;BREu{core}:-0.835698203156;ZNF423:-0.851345994872;FOXQ1:-0.856409412273;FOXD3:-0.864119753122;ZIC1..3:-0.917493557595;HBP1_HMGB_SSRP1_UBTF:-0.940291169782;NFATC1..3:-0.942060602367;NFE2L2:-0.95220800657;ARID5B:-0.966008468766;NANOG{mouse}:-0.979335195522;E2F1..5:-0.979897611898;ZNF238:-0.98710540376;EGR1..3:-1.02432616906;BACH2:-1.02674837148;MTE{core}:-1.04734763674;AHR_ARNT_ARNT2:-1.06486559386;STAT5{A,B}:-1.07114664787;ELF1,2,4:-1.07164639549;FOX{I1,J2}:-1.07653611903;ZFP161:-1.10303228254;KLF4:-1.10442660167;GLI1..3:-1.11415315313;HES1:-1.1246657131;BPTF:-1.14440620284;SMAD1..7,9:-1.18720751242;NRF1:-1.2074196881;EVI1:-1.2267864087;LHX3,4:-1.24279715437;SPIB:-1.25443169011;TOPORS:-1.26694541193;SOX{8,9,10}:-1.27152785238;MZF1:-1.2882140366;YY1:-1.30499751351;DBP:-1.3426538005;POU5F1:-1.34668217689;PRRX1,2:-1.43918159185;GATA4:-1.44711228704;SPZ1:-1.45506991296;POU3F1..4:-1.45954774903;UFEwm:-1.4734801021;TEF:-1.59955410566;IKZF1:-1.62320823931;RORA:-1.66208637229;ELK1,4_GABP{A,B1}:-1.70000092092;RREB1:-1.73982486753;CRX:-1.81581476103;IKZF2:-1.81880687721;PRDM1:-1.82292155247;PITX1..3:-1.8368096744;TAL1_TCF{3,4,12}:-1.85339679704;SOX2:-1.85952768768;CDX1,2,4:-1.89243541765;TFDP1:-1.97969211231;FOXP1:-1.98061070862;CDC5L:-2.00426036186;PAX2:-2.00630110606;EN1,2:-2.01561084636;NKX2-1,4:-2.01611919892;ZNF143:-2.02062602798;VSX1,2:-2.1852943972;NKX3-1:-2.38793852499;PAX4:-2.48679314426;EP300:-2.61189532573;ZBTB16:-2.70527280238;NANOG:-2.7773449805;FOXP3:-2.87663867774;ZNF384:-2.97176325185;AIRE:-3.09194490831
 
|top_motifs=NR1H4:4.33669576105;HLF:4.25349855833;AR:3.55803759212;HNF1A:3.07291260649;NFIL3:2.85179065936;FOXA2:2.79295555977;HNF4A_NR2F1,2:2.5897924603;FOX{F1,F2,J1}:2.46730009914;NFIX:2.34813125642;ESRRA:2.24904849638;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.99247378841;TBP:1.89586746526;FOX{D1,D2}:1.79279189028;PAX1,9:1.78413894012;IRF7:1.69728095698;STAT2,4,6:1.55317055459;NR3C1:1.47320804567;JUN:1.46096487756;bHLH_family:1.43062490842;ESR1:1.36419431699;NR5A1,2:1.36088443716;NKX3-2:1.35138098019;TBX4,5:1.30777138852;MYB:1.24394962771;SNAI1..3:1.18919076864;T:1.09120619869;NR6A1:1.07178004575;CEBPA,B_DDIT3:1.05101438243;PPARG:1.04861708139;NFE2L1:1.0080353541;ZEB1:1.00445087371;ONECUT1,2:0.890146825116;SOX17:0.882358602252;MYOD1:0.839293668886;HAND1,2:0.794489525797;RFX1:0.790620460053;FOXM1:0.711017747061;FOXO1,3,4:0.66449693304;DMAP1_NCOR{1,2}_SMARC:0.618011784381;ATF6:0.561571608976;FOXN1:0.456465258133;TFCP2:0.376434025573;ZBTB6:0.373479008906;PDX1:0.372884397085;TLX1..3_NFIC{dimer}:0.35508229065;RFX2..5_RFXANK_RFXAP:0.337004398854;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.336343583965;PAX6:0.30139817992;PBX1:0.246262444348;FOSL2:0.21371876839;GATA6:0.21119316386;CUX2:0.198509001121;PAX5:0.12077581422;TP53:0.11712987743;ADNP_IRX_SIX_ZHX:0.111844497456;RXRA_VDR{dimer}:0.0969844177456;IRF1,2:0.086123589089;LMO2:0.0841818488891;GZF1:0.066582722117;TLX2:0.0654242590937;GCM1,2:0.014123252449;RBPJ:-0.0178011507238;MYBL2:-0.026462208928;HSF1,2:-0.0348520219673;MAFB:-0.042848048999;REST:-0.0568636076502;ATF5_CREB3:-0.101480400792;SRF:-0.130370723471;NFY{A,B,C}:-0.16718141828;ZNF148:-0.186796491513;LEF1_TCF7_TCF7L1,2:-0.19074552671;TFAP4:-0.197889059456;HOX{A5,B5}:-0.232269196609;STAT1,3:-0.24527216939;MEF2{A,B,C,D}:-0.249491335677;FOS_FOS{B,L1}_JUN{B,D}:-0.266039995085;HOXA9_MEIS1:-0.278472462782;OCT4_SOX2{dimer}:-0.308349911422;GTF2A1,2:-0.313896086094;HMGA1,2:-0.32049719811;RXR{A,B,G}:-0.332669194721;XCPE1{core}:-0.351560045467;NKX2-2,8:-0.364264931338;MYFfamily:-0.367932024705;POU6F1:-0.375761789312;ATF4:-0.379410789966;POU2F1..3:-0.384610499622;ETS1,2:-0.388736769453;SOX5:-0.3904423467;HIC1:-0.393678246847;ATF2:-0.394759549377;TEAD1:-0.420157086187;RUNX1..3:-0.443259282351;TGIF1:-0.480723023818;MTF1:-0.491150002144;GFI1:-0.494573945538;GFI1B:-0.506520278378;ALX1:-0.511993609052;NHLH1,2:-0.532181437146;PATZ1:-0.536308538171;TFAP2{A,C}:-0.540003977572;SREBF1,2:-0.566521214282;FOXL1:-0.569271896245;NFKB1_REL_RELA:-0.571932657702;SP1:-0.597988583849;SPI1:-0.654746679318;HMX1:-0.676229869058;MED-1{core}:-0.676370379993;PAX8:-0.725167035386;NFE2:-0.735415851694;TFAP2B:-0.738796401661;NKX2-3_NKX2-5:-0.748968263641;EBF1:-0.764639918753;HOX{A4,D4}:-0.770620269692;HIF1A:-0.790849855458;ALX4:-0.79118371793;GTF2I:-0.79330664257;POU1F1:-0.805177127056;NKX6-1,2:-0.82336810693;CREB1:-0.834009175763;MAZ:-0.834651704924;BREu{core}:-0.835698203156;ZNF423:-0.851345994872;FOXQ1:-0.856409412273;FOXD3:-0.864119753122;ZIC1..3:-0.917493557595;HBP1_HMGB_SSRP1_UBTF:-0.940291169782;NFATC1..3:-0.942060602367;NFE2L2:-0.95220800657;ARID5B:-0.966008468766;NANOG{mouse}:-0.979335195522;E2F1..5:-0.979897611898;ZNF238:-0.98710540376;EGR1..3:-1.02432616906;BACH2:-1.02674837148;MTE{core}:-1.04734763674;AHR_ARNT_ARNT2:-1.06486559386;STAT5{A,B}:-1.07114664787;ELF1,2,4:-1.07164639549;FOX{I1,J2}:-1.07653611903;ZFP161:-1.10303228254;KLF4:-1.10442660167;GLI1..3:-1.11415315313;HES1:-1.1246657131;BPTF:-1.14440620284;SMAD1..7,9:-1.18720751242;NRF1:-1.2074196881;EVI1:-1.2267864087;LHX3,4:-1.24279715437;SPIB:-1.25443169011;TOPORS:-1.26694541193;SOX{8,9,10}:-1.27152785238;MZF1:-1.2882140366;YY1:-1.30499751351;DBP:-1.3426538005;POU5F1:-1.34668217689;PRRX1,2:-1.43918159185;GATA4:-1.44711228704;SPZ1:-1.45506991296;POU3F1..4:-1.45954774903;UFEwm:-1.4734801021;TEF:-1.59955410566;IKZF1:-1.62320823931;RORA:-1.66208637229;ELK1,4_GABP{A,B1}:-1.70000092092;RREB1:-1.73982486753;CRX:-1.81581476103;IKZF2:-1.81880687721;PRDM1:-1.82292155247;PITX1..3:-1.8368096744;TAL1_TCF{3,4,12}:-1.85339679704;SOX2:-1.85952768768;CDX1,2,4:-1.89243541765;TFDP1:-1.97969211231;FOXP1:-1.98061070862;CDC5L:-2.00426036186;PAX2:-2.00630110606;EN1,2:-2.01561084636;NKX2-1,4:-2.01611919892;ZNF143:-2.02062602798;VSX1,2:-2.1852943972;NKX3-1:-2.38793852499;PAX4:-2.48679314426;EP300:-2.61189532573;ZBTB16:-2.70527280238;NANOG:-2.7773449805;FOXP3:-2.87663867774;ZNF384:-2.97176325185;AIRE:-3.09194490831
 +
|xref=
 
}}
 
}}

Revision as of 06:21, 27 June 2012


Name:Universal RNA - Mouse Normal Tissues Biochain, pool1
Species:Mouse (Mus musculus)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainBalb/C
tissuewhole body
dev stage6-8 weeks old adult
sexmixed
ageNA
cell typeCELL MIXTURE - tissue sample
cell lineNA
companyBiochain
collaborationFANTOM5 OSC CORE (contact: Al Forrest)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot numberB307206
catalog numberCat:R4334566-1
sample typetotal RNA
extraction protocol (Details)OP-RNA-extraction-totalRNA-TRIzol-isopropanol-v1.0
Download raw sequence, BAM & CTSS
Mm9
BAMCTSS
[{{{mm9bam}}} download][{{{mm9ctss}}} donwload]
Mm10
BAMCTSS
[{{{mm10bam}}} download][{{{mm10ctss}}} donwload]


Relative expression to median (log10)


Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.



Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Analyst:NA

link to dataset.
data

CNhs10613

MCL coexpression id Coexpression dpi cluster scores median value
0 0.196
1 0.047
10 0
100 0
1000 0.163
1001 --0.0121
1002 --0.0475
1003 0.00475
1004 0
1005 0.261
1006 0.252
1007 --0.0772
1008 1.686
1009 0.0312
101 --0.0509
1010 0
1011 0.0975
1012 0
1013 0.349
1014 --0.0851
1015 --0.237
1016 --0.251
1017 0
1018 0.227
1019 0.047
102 0
1020 0
1021 --0.00173
1022 0.439
1023 0
1024 0.0834
1025 0.246
1026 0.255
1027 0.0141
1028 0
1029 --0.0678
103 --0.03
1030 0.047
1031 --0.325
1032 0.174
1033 0.0141
1034 0.395
1035 0.047
1036 --0.272
1037 0.128
1038 --0.0576
1039 0.423
104 0.047
1040 --0.126
1041 0.353



Repeat families with enriched expression in this sampleSummary:Ranked list of repeat family expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Analyst:NA

link to dataset.
data
no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample


JASPAR motifsSummary:Association of JASPAR motif to the promoter expression in this sample. Pearson's correlation between the number of TFBSs estimated by using the position-weight matrix for each promoter and its expression is expressed as Z-score by taking the ones based on random position-weight matrix, and the tail probability of the normal distribution corresponding to the Z-score is taken as the resulting P-value. Lower P-value indicates more (non-random) association of the motif to promoter expression
Analyst: Michiel de Hoon


link to dataset.
data

library id: CNhs10613

Jaspar motif P-value
MA0002.2 0.0871
MA0003.1 0.0227
MA0004.1 0.817
MA0006.1 0.255
MA0007.1 0.0366
MA0009.1 0.264
MA0014.1 0.617
MA0017.1 2.23801e-19
MA0018.2 0.819
MA0019.1 0.941
MA0024.1 0.0065
MA0025.1 0.0225
MA0027.1 0.186
MA0028.1 0.0665
MA0029.1 0.577
MA0030.1 0.035
MA0031.1 0.0166
MA0035.2 0.0282
MA0038.1 0.594
MA0039.2 0.087
MA0040.1 0.0943
MA0041.1 0.291
MA0042.1 0.719
MA0043.1 0.371
MA0046.1 1.05311e-86
MA0047.2 2.05608e-4
MA0048.1 0.902
MA0050.1 0.495
MA0051.1 0.162
MA0052.1 0.363
MA0055.1 0.94
MA0057.1 0.367
MA0058.1 0.964
MA0059.1 0.448
MA0060.1 0.327
MA0061.1 0.923
MA0062.2 0.00122
MA0065.2 3.06091e-16
MA0066.1 0.104
MA0067.1 0.413
MA0068.1 0.81
MA0069.1 0.499
MA0070.1 0.857
MA0071.1 0.0476
MA0072.1 0.563
MA0073.1 0.965
MA0074.1 0.373
MA0076.1 0.0183
MA0077.1 0.937
MA0078.1 0.0499
MA0079.2 0.261
MA0080.2 0.771
MA0081.1 0.0469
MA0083.1 0.737
MA0084.1 0.73
MA0087.1 0.948
MA0088.1 0.638
MA0090.1 0.176
MA0091.1 0.84
MA0092.1 0.334
MA0093.1 0.959
MA0099.2 0.84
MA0100.1 5.62472e-4
MA0101.1 0.292
MA0102.2 0.841
MA0103.1 0.00259
MA0104.2 0.714
MA0105.1 0.232
MA0106.1 0.948
MA0107.1 0.173
MA0108.2 9.36828e-5
MA0111.1 0.412
MA0112.2 2.3113e-6
MA0113.1 0.123
MA0114.1 4.07977e-19
MA0115.1 2.63916e-12
MA0116.1 0.102
MA0117.1 0.782
MA0119.1 0.0234
MA0122.1 0.998
MA0124.1 0.332
MA0125.1 0.195
MA0131.1 0.555
MA0135.1 0.7
MA0136.1 0.174
MA0137.2 0.7
MA0138.2 0.0153
MA0139.1 0.274
MA0140.1 0.413
MA0141.1 8.21654e-5
MA0142.1 0.805
MA0143.1 0.127
MA0144.1 0.5
MA0145.1 0.0251
MA0146.1 0.0411
MA0147.1 0.71
MA0148.1 1.01109e-4
MA0149.1 0.168
MA0150.1 0.125
MA0152.1 0.689
MA0153.1 4.56784e-52
MA0154.1 0.0365
MA0155.1 0.388
MA0156.1 0.0557
MA0157.1 0.0683
MA0159.1 0.00336
MA0160.1 9.37665e-6
MA0162.1 0.195
MA0163.1 0.00111
MA0164.1 0.629
MA0258.1 1.17331e-4
MA0259.1 0.588



FANTOM5 phase1 novel unique motifsSummary:Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in 169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above
Analyst: Michiel de Hoon


link to dataset.
data

library id: CNhs10613

Novel motif P-value
1 0.148
10 0.367
100 0.541
101 0.304
102 0.598
103 0.163
104 0.345
105 0.608
106 0.0365
107 0.0696
108 0.769
109 0.0937
11 0.112
110 0.149
111 0.143
112 0.0194
113 0.638
114 0.0265
115 0.523
116 0.159
117 0.381
118 0.436
119 0.126
12 0.756
120 0.588
121 0.0966
122 0.461
123 0.636
124 0.974
125 0.902
126 0.225
127 0.794
128 0.0775
129 0.701
13 0.0263
130 0.908
131 0.409
132 0.362
133 0.447
134 0.93
135 0.372
136 0.143
137 0.949
138 0.855
139 0.0513
14 0.549
140 0.962
141 0.747
142 0.908
143 0.837
144 0.929
145 0.0897
146 0.204
147 0.477
148 0.982
149 0.47
15 0.172
150 0.232
151 0.322
152 0.0902
153 0.856
154 0.811
155 0.823
156 7.11735e-11
157 0.564
158 0.243
159 0.334
160 0.472
161 0.383
162 0.248
163 0.93
164 0.369
165 0.617
166 0.516
167 0.993
168 0.539
169 6.68224e-4
17 0.071
18 0.866
19 0.0566
2 0.52
20 0.978
21 0.651
22 0.146
23 0.26
24 0.0563
25 0.424
26 0.0772
27 0.699
28 0.333
29 0.332
3 0.179
30 0.474
31 0.363
32 0.0385
33 0.447
34 0.47
35 0.322
36 0.18
37 0.128
38 0.69
39 0.332
4 0.829
40 0.0802
41 0.0195
42 0.518
43 0.151
44 0.0708
45 0.297
46 0.191
47 0.14
48 0.137
49 0.164
5 0.266
50 0.67
51 0.536
52 0.159
53 0.99
54 0.496
55 0.764
56 0.6
57 0.944
58 0.204
59 0.0835
6 0.897
60 0.102
61 0.642
62 0.0971
63 0.11
64 0.476
65 0.441
66 0.795
67 0.164
68 0.189
69 0.981
7 0.198
70 0.0464
71 0.162
72 0.36
73 0.16
74 0.323
75 0.107
76 0.707
77 0.108
78 0.525
79 0.728
8 0.00662
80 0.491
81 0.829
82 0.0408
83 0.209
84 0.183
85 0.0257
86 0.22
87 0.0152
88 0.643
89 0.117
9 0.702
90 0.236
91 0.217
92 0.177
93 0.923
94 0.901
95 0.21
96 0.484
97 0.0779
98 0.337
99 0.0921



de novo motifs identified by HOMER in promoters active in this sampleSummary:The result of HOMER in this sample is shown.
Analyst:NA
library id: CNhs10613


FANTOM5 (FF) ontology


Direct parent terms

has_quality relathionship
PATO:0000461

Ancestor terms (non development)Summary:Connected ontology terms with is_a, part_of or located_in relationship
Analyst: Hideya Kawaji

link to source data
data

UBERON: Anatomy
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)

FF: FANTOM5
NA

Ancestor terms (development)Summary:Connected ontology terms with develops_from, derives_from or preceded_by relationship
Analyst: Hideya Kawaji

link to source data
data

NA